FPAS
GOSS icon

Focus Partners Advisor Solutions’s Gossamer Bio GOSS Stock Holding History

Focus Partners Advisor Solutions’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49K Buy
27,305
+1,038
+4% +$290 ﹤0.01% 1243
2026
Q1 		$8.63K Buy
+26,267
New +$41.3K ﹤0.01% 1249

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Focus Partners Advisor Solutions's GOSS Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its Gossamer Bio (GOSS) stake by 4% in Q2 2026, buying an estimated $290 and bringing the position to 27,305 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Focus Partners Advisor Solutions first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.63K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Focus Partners Advisor Solutions held 27,305 shares of Gossamer Bio worth $4.49K as of Q2 2026.
  • Focus Partners Advisor Solutions bought 1,038 Gossamer Bio shares in Q2 2026, an estimated $290.
  • Gossamer Bio made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #1243 holding.
  • Focus Partners Advisor Solutions first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Focus Partners Advisor Solutions's Gossamer Bio position peaked at $8.63K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.